Predictive Oncology Files 2024 10-K
Ticker: AGPU · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1446159
Sentiment: neutral
Topics: 10-K, financials, corporate-actions
TL;DR
POAI filed its 2024 10-K. All good.
AI Summary
Predictive Oncology Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Skyline Medical Inc., is based in Pittsburgh, PA. The filing details its financial performance and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Predictive Oncology Inc.'s financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-K, there are inherent risks associated with financial reporting and market performance.
Key Players & Entities
- Predictive Oncology Inc. (company) — Filer of the 10-K
- Skyline Medical Inc. (company) — Former name of Predictive Oncology Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- Pittsburgh, PA (location) — Company headquarters
FAQ
What was the company's primary business focus during fiscal year 2024?
The filing indicates the company's SIC code is 3842 for Orthopedic, Prosthetic & Surgical Appliances & Supplies, suggesting a focus in this area, though specific business activities for 2024 are detailed within the full report.
When did Predictive Oncology Inc. change its name from Skyline Medical Inc.?
The company changed its name from Skyline Medical Inc. on August 7, 2013.
What is the company's principal executive office address?
The principal executive office is located at 91 43rd Street, Suite 110, Pittsburgh, PA 15201.
What is the SEC file number for Predictive Oncology Inc.?
The SEC file number is 001-36790.
Are there any subsequent events mentioned related to warrants?
Yes, the filing mentions subsequent events on March 25, 2025, related to Series A and Series B warrants.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Predictive Oncology Inc. (AGPU).